WO2015104666A3 - Pharmaceutical composition of fingolimod - Google Patents

Pharmaceutical composition of fingolimod Download PDF

Info

Publication number
WO2015104666A3
WO2015104666A3 PCT/IB2015/050125 IB2015050125W WO2015104666A3 WO 2015104666 A3 WO2015104666 A3 WO 2015104666A3 IB 2015050125 W IB2015050125 W IB 2015050125W WO 2015104666 A3 WO2015104666 A3 WO 2015104666A3
Authority
WO
WIPO (PCT)
Prior art keywords
fingolimod
pharmaceutical composition
lubricant
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
PCT/IB2015/050125
Other languages
French (fr)
Other versions
WO2015104666A2 (en
Inventor
Jaya Abraham
Sujay Rajhans
Tapan BUCH
Original Assignee
Torrent Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Limited filed Critical Torrent Pharmaceuticals Limited
Publication of WO2015104666A2 publication Critical patent/WO2015104666A2/en
Publication of WO2015104666A3 publication Critical patent/WO2015104666A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Present invention relates to a solid oral composition comprising fingolimod or pharmaceutically acceptable salt thereof, diluents selected from powdered cellulose, dicalcium phosphate and tricalcium phosphate; and a lubricant. Invention also relates to process of preparation of solid oral composition comprising fingolimod or pharmaceutically acceptable salt thereof, diluents selected from powdered cellulose, dicalcium phosphate and tricalcium phosphate; and a lubricant.
PCT/IB2015/050125 2014-01-09 2015-01-07 Pharmaceutical composition of fingolimod WO2015104666A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN80MU2014 2014-01-09
IN80/MUM/2014 2014-01-09

Publications (2)

Publication Number Publication Date
WO2015104666A2 WO2015104666A2 (en) 2015-07-16
WO2015104666A3 true WO2015104666A3 (en) 2015-11-12

Family

ID=53524441

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/050125 WO2015104666A2 (en) 2014-01-09 2015-01-07 Pharmaceutical composition of fingolimod

Country Status (1)

Country Link
WO (1) WO2015104666A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016042493A1 (en) * 2014-09-19 2016-03-24 Aizant Drug Research Pvt. Ltd Pharmaceutical compositions of fingolimod
CA3000186A1 (en) * 2015-10-02 2017-04-06 Mylan Inc. Stable formulations of fingolimod
GR1009654B (en) * 2018-08-31 2019-11-18 Φαρματεν Α.Β.Ε.Ε. Pharmaceutical composition comprising an immunomodulatory agent and method for the preparation thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095177A1 (en) * 2010-04-22 2013-04-18 Ratiopharm Gmbh Method of preparing an oral dosage form comprising fingolimod

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095177A1 (en) * 2010-04-22 2013-04-18 Ratiopharm Gmbh Method of preparing an oral dosage form comprising fingolimod

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
5029/CHE/2013, 20 December 2013 (2013-12-20) *

Also Published As

Publication number Publication date
WO2015104666A2 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
EP3349762A4 (en) Co-crystals of sglt2 inhibitors, process for their preparation and pharmaceutical compositions thereof
MX2017014035A (en) Solid forms.
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
WO2017053868A8 (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
WO2016046260A8 (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
EP4327880A3 (en) Solid state form of ribociclib succinate
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
EA201790235A1 (en) METHOD OF OBTAINING cGMP-PHOSPHODESTERASE INHIBITOR AND PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING TADALAFIL CO-PRICIPITATES
TR201721505A2 (en) The combination comprising linagliptin and metformin
EP3564224A3 (en) Crystalline form of vortioxetine hydrobromide as antidepressant drug
WO2015104666A3 (en) Pharmaceutical composition of fingolimod
EA033314B1 (en) ANTIBACTERIALS COMPRISING PYRAZINO[2,3-b][1,4]OXAZIN-3-ONE OR A RELATED RING SYSTEM
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2015001541A3 (en) Pharmaceutical film composition
WO2015181802A3 (en) Oral pharmaceutical composition of isotretinoin
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
WO2017098533A3 (en) Process for preparation of lisdexamphetamine
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
PH12016501205B1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
WO2015131814A3 (en) Use of [(aryloxy)(heteroaryl)]methylpiperidine derivatives in manufacture of medicaments for treatment of depression

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15735078

Country of ref document: EP

Kind code of ref document: A2